Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 11:13 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 281 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Alcohol Abuse, Alcohol Dependence Clear all

Conditions: Alcohol Abuse, Alcohol Dependence
Interventions: Brief Intervention; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 878 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Alcohol Use Disorder
Interventions: Arbaclofen Placarbil, Placebo; Drug
Lead sponsor: Indivior Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Oakland Park, Florida

Conditions: Unhealthy Alcohol Use
Interventions: Contingency Management Counseling, Addiction Physician Management, Motivational Enhancement Therapy; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 7
States / cities: Los Angeles, California • Washington D.C., District of Columbia • Atlanta, Georgia + 4 more

Conditions: PTSD, Alcohol Abuse, Alcoholism
Interventions: Topiramate, Placebo administration; Drug · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Alcohol Abuse, Alcohol Intervention, Transdermal Alcohol Monitoring, Contingency Management, Deposit Contract
Interventions: Deposit Contract, Transdermal Alcohol Monitoring; Behavioral · Other
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 21 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: Denton, Texas • San Antonio, Texas

Conditions: Social Skills, Self-Criticism, Post-traumatic Stress Disorder, Depression, Alcohol Abuse, Drinking, College, Alcohol Drinking, Alcohol; Harmful Use, Social Stigma, Social Norms, Social Responsibility, Social Behavior, Empathy, Coping Skills, Coping Behavior
Interventions: Supporting Survivors and Self: An Intervention for Social Supports of Survivors of Partner Abuse and Sexual Aggression (SSS); Behavioral
Lead sponsor: University of New Hampshire; Other
Eligibility: 18 Years to 24 Years
Enrollment: 1,268 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Durham, New Hampshire

Conditions: Alcohol Abuse
Interventions: AGATE, SASED; Other
Lead sponsor: Talaria, Inc; Industry
Eligibility: 21 Years to 55 Years
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Alcohol Abuse, IPV, Couples
Interventions: Heart Rate Variability-Biofeedback (HRV-B) via Smartwatch Device Intervention; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 21 Years to 70 Years
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Alcohol Abuse
Interventions: Brief Motivational Intervention (BMI), Substance-Free Activity Session (SFAS), Relaxation Session; Behavioral
Lead sponsor: University of Memphis; Other
Eligibility: 18 Years to 27 Years
Enrollment: 393 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 2
States / cities: Columbia, Missouri • Memphis, Tennessee

Conditions: Alcohol Use Disorder, Substance Use, Alcohol Abuse or Dependence
Interventions: Vivitrol (Extended Release Naltrexone); Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 21 Years and older
Enrollment: 179 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Alcohol Drinking, Alcohol Abuse, Alcohol Use Disorder
Interventions: Practice Facilitation; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 13,680 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 2
States / cities: Richmond, Virginia

Conditions: Alcohol Dependence, Alcohol Abuse
Interventions: Motivational Interviewing, Spirit-Only Motivational Interviewing, Self-Change; Behavioral · Other
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 65 Years
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: New York, New York

Conditions: Alcoholism
Interventions: Varenicline, Placebo; Drug
Lead sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA); NIH
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 7
States / cities: Baltimore, Maryland • Boston, Massachusetts • Bedford, New Hampshire + 4 more

Conditions: Alcohol Abuse
Interventions: Personalized Drinking Feedback, Education-Only; Behavioral
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years to 80 Years
Enrollment: 325 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Alcohol Abuse, Alcohol Use Disorder
Interventions: Stand-alone web-based cognitive behavioral therapy (CBT4CBT) for alcohol use disorder; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 248 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Stress Disorders, Post-Traumatic, Alcohol Abuse, Substance-Related Disorders
Interventions: Seeking Safety, Sertraline, Pill placebo; Behavioral · Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 65 Years
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Alcohol Dependence, Problem Drinking, Hazardous Drinking, Human Immunodeficiency Virus, AIDS
Interventions: Vivitrol- Intramuscular naltrexone (depot-formulation), Placebo; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Alcohol Abuse
Interventions: Brief Alcohol Intervention (BAI), Substance-free Activity Session (SFAS), Relaxation Training (RT), Education Control; Behavioral · Other
Lead sponsor: University of Memphis; Other
Eligibility: 18 Years to 29 Years
Enrollment: 525 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Alcohol Use Disorder, Posttraumatic Stress Disorder (PTSD)
Interventions: Prazosin, Naltrexone, Placebo (Prazosin), Placebo (Naltrexone); Drug
Lead sponsor: Seattle Institute for Biomedical and Clinical Research; Other
Eligibility: 18 Years to 80 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Alcohol Dependence
Interventions: Double Placebo, Aripiprazole 15, placebo, Aripiprazole 7.5, Placebo, Topiramate 100, Placebo, Topiramate 200, Placebo, Topiramate 100, Aripiprazole 15, Topiramate 100, Aripiprazole 7.5, Topiramate 100, Aripiprazole 15mg, Topiramate 200, Aripiprazole 7.5mg, Topiramate 200, Aripiprazole 15; Drug
Lead sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2015
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Alcohol Abuse
Interventions: Yoga, Distress Tolerance; Behavioral
Lead sponsor: University of Connecticut; Other
Eligibility: Not listed
Enrollment: 197 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Storrs, Connecticut

Conditions: Alcoholism, Alcohol Abuse, Hepatitis C, Liver Disease
Interventions: 3 session brief intervention with health behavior feedback, treatment as usual; Behavioral · Other
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 80 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Alcohol Abuse, Drug Abuse
Interventions: Multimedia 12-Step Toolkit, Treatment as Usual; Behavioral
Lead sponsor: Treatment Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 3,483 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 11
States / cities: Camden, New Jersey • Brooklyn, New York • Eagleville, Pennsylvania + 2 more

Conditions: Schizophrenia, Schizoaffective Disorder, Psychotic Disorder, Substance Abuse, Alcohol Abuse
Interventions: Quetiapine; Drug
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 4
States / cities: Augusta, Georgia • Lebanon, New Hampshire • Manchester, New Hampshire

Search by objective public record fields.

Disseminating Organizational SBI Services at Trauma Centers

A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcohol Use Disorder

Financial Incentives, Randomization With Stepped Treatment Trial

Topiramate Treatment of Alcohol Use Disorders in Veterans With Post Traumatic Stress Disorder (PTSD): A Pilot Controlled Trial of Augmentation Therapy

Contingency Management Using Deposit Contract to Reduce Drinking

Development and Pilot Trial of an Intervention to Reduce Disclosure Recipients Negative Social Reactions and Victims Psychological Distress and Problem Drinking

Adaptive Goal-Directed Adherence Tracking and Enhancement

Wearable Technology and Alcohol-Facilitated Intimate Partner Violence

Improving Brief Alcohol Interventions With a Behavioral Economic Supplement

Emergency Department Initiated Extended-Release Naltrexone and Case Management for the Treatment of Alcohol Use Disorder

Screening and Management of Unhealthy Alcohol Use in Primary Care

Project Motion, A Study of Motivational Interviewing to Reduce Heavy or Problematic Drinking

Varenicline for Alcohol Dependence

Personalized Drinking Feedback Interventions

Integration of Neurofunctional Phenotyping Into Investigation of CBT4CBT for AUD

Combined Treatment for Alcohol-Dependent Individuals With PTSD

Alcohol Pharmacotherapy for HIV+ Prisoners

Behavioral Economic and Wellness-based Approaches for Reducing Alcohol Use and Consequences Among Emerging Adults

Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders

Aripiprazole and Topiramate on Free-Choice Alcohol Use

Emotion Regulation Interventions for Preventing Collegiate Escalations in Drinking

Health Behavior Feedback Study for Veterans With Hepatitis C

Multimedia Toolkits to Implement 12-Step Recovery Concepts in Group Counseling

Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder